NSGNurse Study Group

NCLEX-style practice question

Which statement explains why carbidopa is combined with levodopa in the treatment of Parkinson's disease?

  1. Carbidopa increases the amount of dopamine that is produced in the brain directly.
  2. Carbidopa blocks acetylcholine receptors so that levodopa has a stronger effect.
  3. Carbidopa stops levodopa from being broken down before it reaches the brain, and it reduces nausea.
  4. Carbidopa allows dopamine itself to cross the blood-brain barrier.
Show answer and rationale

Correct answer: C. Carbidopa stops levodopa from being broken down before it reaches the brain, and it reduces nausea.

Levodopa crosses the blood-brain barrier and is converted to dopamine in the brain, while carbidopa prevents its breakdown before it gets there. Carbidopa also lowers the incidence of levodopa-induced nausea and vomiting. Dopamine itself does not cross the blood-brain barrier, so the option stating that carbidopa allows it to cross is incorrect.

Adapted from Open RN Nursing Pharmacology, Chippewa Valley Technical College, CC BY 4.0.

Category: Pharmacological and Parenteral Therapies / Pharmacological Therapies

Practice every question freeFree account: the full question bank, NCLEX-RN and PN practice exams, flashcards, an AI study tutor and a study group forum.
Create a free account

More Pharmacological and Parenteral Therapies / Pharmacological Therapies questions

See all 440 →

Practice questions are study aids written with AI from openly licensed nursing textbooks and can contain mistakes. They are not NCLEX questions and are not endorsed by NCSBN.